Spanish pharma battles drug price cuts; 2010 pharmacy sales down for many firms
This article was originally published in Scrip
Figures from FEFE, a federation representing pharmacists in Spain, indicate that price cuts in the country have hit pharmaceutical companies hard, with eight of the top 20 firms suffering a decline in sales in 2010. Meanwhile, the pharmaceutical supply chain is presenting a united front to protest against austerity measures from both national government and regional health authorities.
You may also be interested in...
The R&D-based lobby group, Medicines Australia, has published a report calling for stakeholders across the Australian healthcare ecosystem to discuss how to “pragmatically address the evidence needs of the future.”
NICE will review new data in deciding whether to ok the use of Spinraza in non-ambulant SMA type III patients.
WTO member states including the EU, the US and the UK argue that waiving certain IP rights is unnecessary for enhancing responses to the Covid-19 pandemic.